Emergency reversal of anticoagulation: from theory to real use of prothrombin complex concentrates. A retrospective Italian experience. (otvara se novi prozor)

Barillari G, Pasca S, Barillari A, De Angelis V.

Izvor‎: Blood Transfus 2012;10(1):87-94.

Indeks‎: PubMed 22044952

DOI‎: 10.2450/2011.0030-11

https://www.ncbi.nlm.nih.gov/pubmed/22044952 (otvara se novi prozor)

Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (otvara se novi prozor)

Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, Dunn AS, Kunz R; American College of Chest Physicians.

Izvor‎: Chest 2012;141(2 Suppl):e326S-50S.

Indeks‎: PubMed 22315266

DOI‎: 10.1378/chest.11-2298

https://www.ncbi.nlm.nih.gov/pubmed/22315266 (otvara se novi prozor)

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (otvara se novi prozor)

Goldstein JN, Refaai MA, Milling TJ Jr, Lewis B, Goldberg-Alberts R, Hug BA, Sarode R.

Izvor‎: Lancet 2015;385(9982):2077-87.

Indeks‎: PubMed 25728933

DOI‎: 10.1016/S0140-6736(14)61685-8

https://www.ncbi.nlm.nih.gov/pubmed/25728933 (otvara se novi prozor)

Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): a pharmacovigilance study. (otvara se novi prozor)

Hanke AA, Joch C, Görlinger K.

Izvor‎: Br J Anaesth 2013;110(5):764-72.

Indeks‎: PubMed 23335567

DOI‎: 10.1093/bja/aes501

https://www.ncbi.nlm.nih.gov/pubmed/23335567 (otvara se novi prozor)

Emergency reversal of warfarin anticoagulation. (otvara se novi prozor)

Lin Y, Callum J.

Izvor‎: CMAJ 2010;182(18):2004.

Indeks‎: PubMed 21078740

DOI‎: 10.1503/cmaj.100983

https://www.ncbi.nlm.nih.gov/pubmed/21078740 (otvara se novi prozor)

Recent advances in the development of specific antidotes for target-specific oral anticoagulants. (otvara se novi prozor)

Mo Y, Yam FK.

Izvor‎: Pharmacotherapy 2015;35(2):198-207.

Indeks‎: PubMed 25644580

DOI‎: 10.1002/phar.1532

https://www.ncbi.nlm.nih.gov/pubmed/25644580 (otvara se novi prozor)

Idarucizumab for dabigatran reversal - full cohort analysis. (otvara se novi prozor)

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

Izvor‎: N Engl J Med 2017;377(5):431-41.

Indeks‎: PubMed 28693366

DOI‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 (otvara se novi prozor)

Oral anticoagulation in surgical procedures: risks and recommendations. (otvara se novi prozor)

Torn M, Rosendaal FR.

Izvor‎: Br J Haematol 2003;123(4):676-82.

Indeks‎: PubMed 14616972

https://www.ncbi.nlm.nih.gov/pubmed/14616972 (otvara se novi prozor)